Peris K - Search Results

1

Differences in clinicopathological features and distribution of risk factors in Italian melanoma patients.

Fava P, Astrua C, Chiarugi A, Crocetti E, Pimpinelli N, Fargnoli MC, Maurichi A, Rubegni P, Manganoni AM, Bottoni U, Catricalà C, Cavicchini S, Santinami M, Alaibac M, Annetta A, Borghi A, Calzavara Pinton P, Capizzi R, Clerico R, Colombo E, Corradin MT, De Simone P, Fantini F, Ferreli C, Filosa G, Girgenti V, Giulioni E, Guarneri C, Lamberti A, Lisi P, Nardini P, Papini M, Peris K, Pizzichetta MA, Salvini C, Savoia P, Strippoli D, Tolomio E, Tomassini MA, Vena GA, Zichichi L, Patrizi A, Argenziano G, Simonacci M, Quaglino P. Fava P, et al. Among authors: peris k. Dermatology. 2015;230(3):256-62. doi: 10.1159/000368775. Epub 2015 Jan 31. Dermatology. 2015. PMID: 25659983 Free article.

2

Use of recombinant interferon alfa-2b in the treatment of basal cell carcinoma.

Chimenti S, Peris K, Di Cristofaro S, Fargnoli MC, Torlone G. Chimenti S, et al. Among authors: peris k. Dermatology. 1995;190(3):214-7. doi: 10.1159/000246688. Dermatology. 1995. PMID: 7599384 Clinical Trial.

3

Penile metastases from bladder carcinoma.

Filosa G, Bugatti L, Peris K, Chimenti S. Filosa G, et al. Among authors: peris k. Acta Derm Venereol. 1996 May;76(3):250-1. doi: 10.2340/0001555576250251. Acta Derm Venereol. 1996. PMID: 8800318 Free article. No abstract available.

4

Multiple microsatellite alterations on chromosome 9 in neurofibromas of NF-1 patients.

Fargnoli MC, Chimenti S, Peris K. Fargnoli MC, et al. Among authors: peris k. J Invest Dermatol. 1997 May;108(5):812-3. doi: 10.1111/1523-1747.ep12292279. J Invest Dermatol. 1997. PMID: 9129239 Free article. No abstract available.

5

Peripheral nervous system involvement in a patient with large T-cell lymphoma arising from a pre-existing mycosis fungoides.

Peris K, Fargnoli MC, Berardelli A, Crecco M, Tomaselli R, Chimenti S. Peris K, et al. Br J Dermatol. 1998 Aug;139(2):299-301. doi: 10.1046/j.1365-2133.1998.02371.x. Br J Dermatol. 1998. PMID: 9767248

6

CDKN2a/p16INK4a mutations and lack of p19ARF involvement in familial melanoma kindreds.

Fargnoli MC, Chimenti S, Keller G, Soyer HP, Dal Pozzo V, Höfler H, Peris K. Fargnoli MC, et al. Among authors: peris k. J Invest Dermatol. 1998 Dec;111(6):1202-6. doi: 10.1046/j.1523-1747.1998.00412.x. J Invest Dermatol. 1998. PMID: 9856841 Free article.

7

UV fingerprint CDKN2a but no p14ARF mutations in sporadic melanomas.

Peris K, Chimenti S, Fargnoli MC, Valeri P, Kerl H, Wolf P. Peris K, et al. J Invest Dermatol. 1999 May;112(5):825-6. doi: 10.1046/j.1523-1747.1999.00575.x. J Invest Dermatol. 1999. PMID: 10233780 Free article. No abstract available.

8

Reduced expression of CDKN2a/P16INK4a in mycosis fungoides.

Peris K, Stanta G, Fargnoli MC, Bonin S, Felli A, Amantea A, Chimenti S. Peris K, et al. Arch Dermatol Res. 1999 Apr;291(4):207-11. doi: 10.1007/s004030050395. Arch Dermatol Res. 1999. PMID: 10335917

9

The use of chemical peelings in the treatment of different cutaneous hyperpigmentations.

Cotellessa C, Peris K, Onorati MT, Fargnoli MC, Chimenti S. Cotellessa C, et al. Among authors: peris k. Dermatol Surg. 1999 Jun;25(6):450-4. doi: 10.1046/j.1524-4725.1999.08217.x. Dermatol Surg. 1999. PMID: 10469091 Clinical Trial.

10

Preliminary observations on the use of topical tazarotene to treat basal-cell carcinoma.

Peris K, Fargnoli MC, Chimenti S. Peris K, et al. N Engl J Med. 1999 Dec 2;341(23):1767-8. doi: 10.1056/NEJM199912023412312. N Engl J Med. 1999. PMID: 10610445 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

596 results

Search Page